Salmonellae are facultative intracellular pathogens that cause disease in humans and animals. Infections by these organisms result in a spectrum of diseases including enteric (typhoid) fever, gastroenteritis and bacteremias. These infections are more common and severe in infants and the elderly, as well as immunosuppressed individuals, including those with AIDS. Non-typhoidal Salmonella infections are often associated with contaminated food, including frequent egg-related outbreaks of Salmonella enteritidis. Salmonella typhimurium infection of mice causes a similar illness to, and is a model for, Salmonella typhi infection of humans. The overall objectives of this work are to better understand the induction of pathogenic bacterial gene expression in response to eukaryotic cell environments, as well as how bacteria utilize regulatory networks induced within these environments to avoid host defense mechanisms. S. typhimurium is able to survive within host phagocytic cells, a major site of production of antimicrobial peptides (AP). These cationic, broadly cytotoxic peptides are a major factor of the innate immune system. S. typhimurium has developed mechanisms of resistance to these peptides, and resistance is controlled by the in vivo induced two-component regulatory systems PhoP-PhoQ and PmrA-PmrB. PmrA-PmrB activation results in LPS modification and greatly reduced binding of the peptides to the surface of the organisms; however, the PmrA-PmrB regulated effectors and the mechanism(s) by which LPS modification occurs are unknown. The goal of this proposal is to characterize the PmrA-PmrB regulon, which includes identification and characterization of regulated genes whose products affect LPS structure and subsequent antimicrobial peptide resistance. These goals will be accomplished by (1) Genetic and functional characterization of the pmrF locus, a putative six gene operon necessary for AP resistance and modification of LPS with aminoarabinose; (2) Identification and characterization of additional PmrA-PmrB regulated genes necessary for AP resistance and LPS modification; (3) Definition of the role of PmrA-PmrB mediated LPS modification in S. typhimurium virulence and survival within professional phagocytes; and (4) Definition of cis-acting sequences necessary for PmrA binding to PmrA-PmrB regulated gene promoters. It is hoped that these studies will increase our understanding of the molecular basis of Salmonella pathogenesis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
7R29AI043521-06
Application #
6757146
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Program Officer
Schmitt, Clare K
Project Start
1998-07-15
Project End
2003-12-31
Budget Start
2003-06-01
Budget End
2003-12-31
Support Year
6
Fiscal Year
2002
Total Cost
$31,505
Indirect Cost
Name
Ohio State University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Donius, Luke R; Weis, Janis J; Weis, John H (2014) Murine complement receptor 1 is required for germinal center B cell maintenance but not initiation. Immunobiology 219:440-9
Donius, Luke R; Orlando, Christopher M; Weis, Janis J et al. (2014) Generation of a novel Cr2 gene allele by homologous recombination that abrogates production of Cr2 but is sufficient for expression of Cr1. Immunobiology 219:53-63
Donius, Luke R; Handy, Jennifer M; Weis, Janis J et al. (2013) Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1. J Immunol 191:434-47
Strandberg, Kristi L; Richards, Susan M; Gunn, John S (2012) Cathelicidin antimicrobial peptide expression is not induced or required for bacterial clearance during salmonella enterica infection of human monocyte-derived macrophages. Infect Immun 80:3930-8
Lochhead, Robert B; Sonderegger, F Lynn; Ma, Ying et al. (2012) Endothelial cells and fibroblasts amplify the arthritogenic type I IFN response in murine Lyme disease and are major sources of chemokines in Borrelia burgdorferi-infected joint tissue. J Immunol 189:2488-501
Sonderegger, F Lynn; Ma, Ying; Maylor-Hagan, Heather et al. (2012) Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-?-mediated Lyme arthritis. J Immunol 188:1381-93
Pastelin-Palacios, Rodolfo; Gil-Cruz, Cristina; PĂ©rez-Shibayama, Christian I et al. (2011) Subversion of innate and adaptive immune activation induced by structurally modified lipopolysaccharide from Salmonella typhimurium. Immunology 133:469-81
Richards, Susan M; Strandberg, Kristi L; Gunn, John S (2010) Salmonella-regulated lipopolysaccharide modifications. Subcell Biochem 53:101-22
Kim, Byoungkwan; Richards, Susan M; Gunn, John S et al. (2010) Protecting against antimicrobial effectors in the phagosome allows SodCII to contribute to virulence in Salmonella enterica serovar Typhimurium. J Bacteriol 192:2140-9
Miller, Jennifer C; Maylor-Hagen, Heather; Ma, Ying et al. (2010) The Lyme disease spirochete Borrelia burgdorferi utilizes multiple ligands, including RNA, for interferon regulatory factor 3-dependent induction of type I interferon-responsive genes. Infect Immun 78:3144-53

Showing the most recent 10 out of 11 publications